[Protein kinases C: a new cytoplasmic target]

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Protein kinase C (PKC) are serine-threonine kinases involved in cellular signaling.
• Deregulated PKC expression is observed in various cancers, but their roles can be isoform- and cell type-specific, exhibiting both pro- and anti-proliferative effects.
• The precise involvement of PKC in tumor development remains incompletely understood.

Purpose of the Study:

• To review current data on the role of Protein Kinase C (PKC) in oncogenesis.
• To emphasize the clinical outcomes associated with PKC dysregulation and therapeutic strategies.
• To provide a comprehensive overview of PKC's complex involvement in cancer development.

Main Methods:

• Literature review of existing studies on PKC and cancer.
• Analysis of data on PKC isoform expression in different tumor types.
• Evaluation of clinical trial data and outcomes related to PKC-targeting agents.

Main Results:

• PKC's role in oncogenesis is complex and highly variable, depending on the specific PKC isoform and cellular context.
• Evidence suggests both tumor-promoting and tumor-suppressing functions for different PKC members.
• Clinical data on agents targeting PKC in cancer treatment show variable outcomes, necessitating further research.

Conclusions:

• Understanding the specific roles of PKC isoforms in cancer is crucial for developing effective therapies.
• Targeting PKC in cancer treatment requires careful consideration of isoform specificity and potential side effects.
• Further research is needed to fully elucidate PKC's complex role in oncogenesis and optimize therapeutic strategies.